Evidence map›Paper›PMID 19047592›Full record

ReviewCirculation2008

Circulating markers of abdominal aortic aneurysm presence and progression.

Jonathan Golledge, Philip S Tsao, Ronald L Dalman, Paul E Norman

Registry-linked trialAbstract readReview
In one paragraph

Review in Circulation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01683084 (Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms), which is not on this map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01683084 phase4completednot on this mapstarted 2012, after this paper: background citation

Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms

TypeinterventionalSponsorPalo Alto Veterans Institute for ResearchRan2012 to 2018Enrolled22ConditionsAbdominal Aortic AneurysmArmsTelmisartan, Placebo
3 · Its place in the literature

Who cites it

95 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Review
  14. Article
  15. Innovation in pathogenesis and management of aortic aneurysm.World journal of experimental medicine · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan GolledgeVascular Biology Unit, Department of Surgery, School of Medicine, James Cook University, Townsville, Queensland, Australia. jonathan.golledge@jcu.edu.au
Philip S Tsao
Ronald L Dalman
Paul E Norman

Funding

Signature Protein Profiles to Identify AAAsP50HL083800 · NHLBI · STANFORD UNIVERSITY · PI DALMAN, RONALD L · 2006 to 2010
$13.7M
Osteoprotegerin and osteopontin in aortic aneurysmR01HL080010 · NHLBI · JAMES COOK UNIVERSITY OF NO QUEENSLAND · PI GOLLEDGE, JONATHAN · 2005 to 2009
$1.3M
NHLBI NIH HHS P50 HL083800-03NHLBI NIH HHS R01 HL080010NHLBI NIH HHS R01 HL080010-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aortic Aneurysm, AbdominalBiomarkersCytokinesDisease ProgressionExtracellular Matrix ProteinsHumansInflammationThrombosisBiomarkersCytokinesExtracellular Matrix Proteins

Identifiers

PMID19047592
PMCPMC2752737

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.